Viridian Therapeutics Inc. has approved the grant of non-qualified stock options for three new employees, totaling 171,900 shares of the company's common stock. The options will have an exercise price equal to the closing price on the grant date, December 1, 2025. Vesting will occur over four years, with 25% of the shares vesting after the first year and the remainder vesting in 36 equal monthly installments, contingent on continued employment.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viridian Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251205462722) on December 05, 2025, and is solely responsible for the information contained therein.